SV2009002911A - Formulaciones de proteina de fusion inmunologica ref. 08702.0148-00267 (am101862 sv) - Google Patents
Formulaciones de proteina de fusion inmunologica ref. 08702.0148-00267 (am101862 sv)Info
- Publication number
- SV2009002911A SV2009002911A SV2008002911A SV2008002911A SV2009002911A SV 2009002911 A SV2009002911 A SV 2009002911A SV 2008002911 A SV2008002911 A SV 2008002911A SV 2008002911 A SV2008002911 A SV 2008002911A SV 2009002911 A SV2009002911 A SV 2009002911A
- Authority
- SV
- El Salvador
- Prior art keywords
- compositions
- fusion protein
- protein formulations
- immune fusion
- liofilized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A COMPOSICIONES DE PROTEÍNAS DE FUSIÓN DE IG, ESPECIALMENTE COMPOSICIONES QUE INCLUYEN UNA PROTEÍNA DE FUSIÓN DE IG, UN AGENTE DE VOLUMEN, UN DISACÁRIDO, UN TENSIOACTIVO, Y UN AMORTIGUADOR. EN UN ASPECTO, ESTAS COMPOSICIONES SON ESTABLES BAJO ALMACENAMIENTO A LARGO PLAZO O AL MENOS UN CICLO DE CONGELACIÓN/DESCONGELACIÓN. LA INVENCIÓN TAMBIÉN PROPORCIONA MÉTODOS DE PREPARACIÓN DE LAS COMPOSICIONES DE PROTEÍNA DE FUSIÓN DE IG. EN UN ASPECTO, LAS COMPOSICIONES DE LA INVENCIÓN SON LIOFILIZADAS. EN UN ASPECTO ADICIONAL, LAS COMPOSICIONES SON LIOFILIZADAS POR UN PROCESO QUE INCLUYE UNA ETAPA DE RECOCIDO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73927105P | 2005-11-22 | 2005-11-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV2009002911A true SV2009002911A (es) | 2009-03-04 |
Family
ID=37781927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV2008002911A SV2009002911A (es) | 2005-11-22 | 2008-05-22 | Formulaciones de proteina de fusion inmunologica ref. 08702.0148-00267 (am101862 sv) |
Country Status (14)
Country | Link |
---|---|
US (2) | US20070237758A1 (es) |
EP (1) | EP1951305A1 (es) |
JP (1) | JP2009516692A (es) |
KR (1) | KR20080071192A (es) |
CN (1) | CN101312744A (es) |
AU (1) | AU2006318583A1 (es) |
BR (1) | BRPI0618893A2 (es) |
CA (1) | CA2630115A1 (es) |
CR (1) | CR10012A (es) |
EC (1) | ECSP088459A (es) |
NO (1) | NO20082133L (es) |
RU (1) | RU2008118166A (es) |
SV (1) | SV2009002911A (es) |
WO (1) | WO2007062040A1 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2377554A1 (en) * | 2005-07-22 | 2011-10-19 | Amgen, Inc | Concentrated protein lyophilates, methods and uses |
US20090060906A1 (en) * | 2007-01-09 | 2009-03-05 | Wyeth | Anti-IL-13 antibody formulations and uses thereof |
JP2010519220A (ja) * | 2007-02-16 | 2010-06-03 | ワイス エルエルシー | マンニトール誘導性のタンパク質凝集を抑制するためのスクロースの使用 |
US8637021B2 (en) * | 2007-11-12 | 2014-01-28 | Ares Trading S.A. | Formulations for TACI-immunoglobulin fusion proteins |
AR076284A1 (es) | 2009-04-29 | 2011-06-01 | Bayer Schering Pharma Ag | Inmunoconjugados de antimesotelina y usos de los mismos |
CA2764180A1 (en) * | 2009-06-18 | 2010-12-23 | Wyeth Llc | Lyophilized formulations for small modular immunopharmaceuticals |
CN101693016B (zh) * | 2009-11-02 | 2012-07-25 | 北京美福源生物医药科技有限公司 | 通用的注射用重组人血清白蛋白融合蛋白制剂配方 |
EP2496246B1 (en) | 2009-11-03 | 2018-06-27 | Grifols Therapeutics LLC | Composition, method, and kit for alpha-1 proteinase inhibitor |
PL2503995T3 (pl) * | 2009-11-24 | 2018-01-31 | Grifols Therapeutics Inc | Sposoby liofilizacji, kompozycje i zestawy |
JO3417B1 (ar) | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
AR087305A1 (es) | 2011-07-28 | 2014-03-12 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit |
TWI589299B (zh) | 2011-10-11 | 2017-07-01 | 再生元醫藥公司 | 用於治療類風濕性關節炎之組成物及其使用方法 |
CN105435222B (zh) * | 2014-09-25 | 2018-05-29 | 信达生物制药(苏州)有限公司 | 重组融合蛋白制剂 |
CN104940926B (zh) * | 2014-09-25 | 2017-09-22 | 信达生物制药(苏州)有限公司 | 重组融合蛋白制剂 |
GB201513010D0 (en) | 2015-07-23 | 2015-09-09 | Glaxosmithkline Biolog Sa | Novel formulation |
US10772956B2 (en) | 2015-08-18 | 2020-09-15 | Regeneron Pharmaceuticals, Inc. | Methods for reducing or eliminating the need for lipoprotein apheresis in patients with hyperlipidemia by administering alirocumab |
CN112739323A (zh) | 2018-05-10 | 2021-04-30 | 瑞泽恩制药公司 | 含有高浓度vegf受体融合蛋白的制剂 |
WO2020021330A2 (en) * | 2018-07-12 | 2020-01-30 | Endo Global Aesthetics Limited | Injection techniques for the treatment of cellulite |
WO2020088481A1 (zh) * | 2018-10-30 | 2020-05-07 | 中国科学院化学研究所 | 一种制备药物或药物中间体单晶或无定型物的方法 |
CN111195349B (zh) * | 2018-11-16 | 2023-02-24 | 鲁南制药集团股份有限公司 | 一种代谢调节融合蛋白的冻干粉制剂 |
KR20210113271A (ko) * | 2019-01-06 | 2021-09-15 | 엔도 글로벌 에스테틱스 리미티드 | 콜라게나제 제형 및 이의 제조 방법 |
US11498969B2 (en) | 2019-01-31 | 2022-11-15 | Sanofi Biotechnology | Compositions and methods for treating juvenile idiopathic arthritis |
CR20210435A (es) | 2019-02-18 | 2021-09-20 | Lilly Co Eli | Formulación de anticuerpos terapéuticos |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4597966A (en) * | 1985-01-09 | 1986-07-01 | Ortho Diagnostic Systems, Inc. | Histidine stabilized immunoglobulin and method of preparation |
US5843707A (en) * | 1992-10-23 | 1998-12-01 | Genetics Institute, Inc. | Nucleic acid encoding a novel P-selectin ligand protein |
US6372716B1 (en) * | 1994-04-26 | 2002-04-16 | Genetics Institute, Inc. | Formulations for factor IX |
AU716785B2 (en) * | 1995-07-27 | 2000-03-09 | Genentech Inc. | Stabile isotonic lyophilized protein formulation |
US6685940B2 (en) * | 1995-07-27 | 2004-02-03 | Genentech, Inc. | Protein formulation |
US5763401A (en) * | 1996-07-12 | 1998-06-09 | Bayer Corporation | Stabilized albumin-free recombinant factor VIII preparation having a low sugar content |
JP3900664B2 (ja) * | 1997-09-26 | 2007-04-04 | 株式会社ニコン | 顕微鏡 |
US7198789B2 (en) * | 1998-03-17 | 2007-04-03 | Genetics Institute, Llc | Methods and compositions for modulating interleukin-21 receptor activity |
DE60035260T2 (de) * | 1999-02-22 | 2007-10-18 | The University Of Connecticut, Farmington | Neue albuminfreie faktor viii formulierungen |
WO2000066160A1 (fr) * | 1999-04-28 | 2000-11-09 | Yamanouchi Pharmaceutical Co., Ltd. | Composition medicamenteuse parenterale a fragment d'anticorps monoclonal humanise et procede de stabilisation |
AU2003219958B2 (en) * | 2002-02-27 | 2006-01-05 | Immunex Corporation | Polypeptide formulation |
CA2554018A1 (en) * | 2004-03-04 | 2005-09-29 | Wyeth | Lyophilization method to improve excipient crystallization |
-
2006
- 2006-11-21 KR KR1020087015109A patent/KR20080071192A/ko not_active Application Discontinuation
- 2006-11-21 JP JP2008541422A patent/JP2009516692A/ja not_active Withdrawn
- 2006-11-21 CA CA002630115A patent/CA2630115A1/en not_active Abandoned
- 2006-11-21 BR BRPI0618893-1A patent/BRPI0618893A2/pt not_active IP Right Cessation
- 2006-11-21 US US11/562,299 patent/US20070237758A1/en not_active Abandoned
- 2006-11-21 AU AU2006318583A patent/AU2006318583A1/en not_active Abandoned
- 2006-11-21 RU RU2008118166/15A patent/RU2008118166A/ru not_active Application Discontinuation
- 2006-11-21 EP EP06838185A patent/EP1951305A1/en not_active Withdrawn
- 2006-11-21 CN CNA2006800437873A patent/CN101312744A/zh active Pending
- 2006-11-21 WO PCT/US2006/045059 patent/WO2007062040A1/en active Application Filing
-
2008
- 2008-05-07 NO NO20082133A patent/NO20082133L/no not_active Application Discontinuation
- 2008-05-19 EC EC2008008459A patent/ECSP088459A/es unknown
- 2008-05-22 CR CR10012A patent/CR10012A/es not_active Application Discontinuation
- 2008-05-22 SV SV2008002911A patent/SV2009002911A/es unknown
-
2010
- 2010-10-22 US US12/910,146 patent/US20110033464A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1951305A1 (en) | 2008-08-06 |
BRPI0618893A2 (pt) | 2011-09-13 |
CN101312744A (zh) | 2008-11-26 |
WO2007062040A1 (en) | 2007-05-31 |
CA2630115A1 (en) | 2007-05-31 |
CR10012A (es) | 2008-07-29 |
ECSP088459A (es) | 2008-06-30 |
KR20080071192A (ko) | 2008-08-01 |
NO20082133L (no) | 2008-06-16 |
JP2009516692A (ja) | 2009-04-23 |
AU2006318583A1 (en) | 2007-05-31 |
US20110033464A1 (en) | 2011-02-10 |
RU2008118166A (ru) | 2009-12-27 |
US20070237758A1 (en) | 2007-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2009002911A (es) | Formulaciones de proteina de fusion inmunologica ref. 08702.0148-00267 (am101862 sv) | |
HK1205193A1 (en) | Recombinant n-glycosylated proteins from procaryotic cells n- | |
GT200800132A (es) | Anticuerpos anti-il-23 humanos, composiciones, metodos y usos | |
WO2007067730A3 (en) | Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use | |
WO2008030968A3 (en) | Fusion peptide therapeutic compositions | |
WO2007147001A3 (en) | Lyophilized formulations of anti-egfr antibodies | |
BRPI0514340A (pt) | formulações de estabilização | |
CO5720212A1 (es) | Composicion de anticuerpo her2 | |
HN2006016512A (es) | Anticuerpos anti-il-6, composiciones, metodos y usos | |
ATE463515T1 (de) | Chimaere rekombinante antigene von toxoplasma gondii | |
WO2009142460A3 (en) | Antibody-peptide fused synergibody | |
HK1093012A1 (en) | Stable, aqueous solution of human erythropoietin, not containing serum albumin | |
ATE304866T1 (de) | Chelatorkonjugate mit verbesserten eigenschaften | |
ATE389397T1 (de) | Adjuvante zusammensetzungen | |
WO2006125201A3 (en) | Anti-biotin-pegylated-mcp-1 mutein antibodies, compositions, methods and uses | |
ATE439443T1 (de) | NEUES Aß-BINDUNGSPROTEIN UND DESSEN PEPTIDDERIVATE SOWIE VERWENDUNGEN DAVON | |
WO2002030982A3 (en) | Endostatin and pitslre protein kinases as angiogenesis-inhibiting peptides and method of use | |
WO2003049672A3 (en) | Methods and compositions for treating flavivirus-mediated disease | |
WO2007100384A3 (en) | Three frame cdna expression libraries for functional screening of proteins | |
AR055442A1 (es) | Variantes de la egln2 y su uso enla prevencion o tratamiento de tromboembolias y cardiopatias isquemicas | |
WO2006119994A3 (de) | Verfahren zur herstellung von albumin-konjugaten mit einem röntgenkontrastmittel als wirkstoff | |
BENBACERING | Death of Living Buddha Bomi |